Jaglix 25 mg filmom obložene tablete
| Name | Jaglix 25 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-791550362 |
| Active Substance | sitagliptinklorid hidrat |
| Composition | jedna tableta sadrži sitagliptinklorid hidrat što odgovara 25 mg sitagliptina |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Mylan Hungary Kft, Komárom, Mađarska Medis International A.S., Bolatice, Češka |
| Marketing Authorisation Holder | Viatris Limited, Damastown Industrial Park, Mulhuddart, Dublin, Irska |
| Marketing Authorisation Date | 10.11.2025 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/25-02/96 |
| Registration Number | 381-12-01/171-25-06 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | A10BH01 |
| Marketing status | Marketed |
| Shortage status | Actual |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
